Literature DB >> 1654405

Stereological estimates of nuclear volume and other quantitative variables in supratentorial brain tumors. Practical technique and use in prognostic evaluation.

F B Sørensen1, H Braendgaard, A O Chistiansen, M Bojsen-Møller, E Reske-Nielsen.   

Abstract

The use of morphometry and modern stereology in malignancy grading of brain tumors is only poorly investigated. The aim of this study was to present these quantitative methods. A retrospective feasibility study of 46 patients with supratentorial brain tumors was carried out to demonstrate the practical technique. The continuous variables were correlated with the subjective, qualitative WHO classification of brain tumors, and the prognostic value of the parameters was assessed. Well differentiated astrocytomas (n = 14) had smaller estimates of the volume-weighted mean nuclear volume and mean nuclear profile area, than those of anaplastic astrocytomas (n = 13) (2p = 3.1.10(-3) and 2p = 4.8.10(-3), respectively). No differences were seen between the latter type of tumor and glioblastomas (n = 19). The nuclear index was of the same magnitude in all three tumor types, whereas the mitotic index was significantly increased in glioblastomas (2p = 0.01). Three-dimensional, shape-independent estimates of macroscopical tumor volume were not different in anaplastic astrocytomas and glioblastomas (2p = 0.39). Histological type of tumor and mitotic index were of significant prognostic value (2p = 8.2.10(-6) and 2p approximately 0.05, respectively). Age above the median and short duration of symptoms were significantly associated with short survival (2p = 0.01). Further investigations of larger series of patients are needed to define the clinical usefulness of these objective, reproducible, and quantitative techniques in the prognostic evaluation of primary brain tumors.

Entities:  

Mesh:

Year:  1991        PMID: 1654405     DOI: 10.1007/bf00177538

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  31 in total

1.  Optimizing sampling efficiency of stereological studies in biology: or 'do more less well!'.

Authors:  H J Gundersen; R Osterby
Journal:  J Microsc       Date:  1981-01       Impact factor: 1.758

2.  Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors.

Authors:  F Cohadon; N Aouad; A Rougier; C Vital; J Rivel; J F Dartigues
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

3.  Present status and future role of surgery for malignant supratentorial gliomas.

Authors:  J Garfield
Journal:  Neurosurg Rev       Date:  1986       Impact factor: 3.042

4.  Objective histopathologic grading of cutaneous malignant melanomas by stereologic estimation of nuclear volume. Prediction of survival and disease-free period.

Authors:  F B Sørensen
Journal:  Cancer       Date:  1989-05-01       Impact factor: 6.860

5.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

Review 6.  Chemotherapy for malignant gliomas.

Authors:  P L Kornblith; M Walker
Journal:  J Neurosurg       Date:  1988-01       Impact factor: 5.115

7.  Automated image analysis, histologic malignancy grading, and survival in patients with astrocytic gliomas. Prognostic significance of nuclear count and nuclear area fraction.

Authors:  L H Klinken; N H Diemer; F Gjerris
Journal:  Clin Neuropathol       Date:  1984 May-Jun       Impact factor: 1.368

8.  Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.

Authors:  P Zuber; M F Hamou; N de Tribolet
Journal:  Neurosurgery       Date:  1988-02       Impact factor: 4.654

9.  Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

Authors:  D F Nelson; J S Nelson; D R Davis; C H Chang; T W Griffin; T F Pajak
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

10.  Anaplastic astrocytoma of the adult cerebrum. Prognostic value of histologic features.

Authors:  K H Fulling; D M Garcia
Journal:  Cancer       Date:  1985-03-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.